ras oncogene mutations in diethylnitrosamine-induced hepatic tumors in medaka (Oryzias latipes), a teleost fish

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 539, Issue 1-2, 2003, Pages 43-53

  Liu, Zi ^a   Kullman, Seth W ^b   Bencic, David C ^b   Torten, Michael ^a   Hinton, David E ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

Diethylnitrosamine; Hepatic carcinogenesis; Medaka; ras mutations

Indexed keywords

ASPARAGINE; ASPARTIC ACID; DIETHYLNITROSAMINE; DNA; GENE PRODUCT; GLYCINE; LYSINE; THREONINE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT TUMOR; CARCINOGENICITY; CODON; CONTROLLED STUDY; CYPRINODONTIFORMES; DNA DETERMINATION; DNA MICROARRAY; DNA POLYMORPHISM; DNA PROBE; DRUG EXPOSURE; EXON; GENE ACTIVATION; GENE AMPLIFICATION; GENE INDUCTION; GENE LOCUS; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; IN VIVO STUDY; LIVER ADENOMA; LIVER CARCINOGENESIS; LIVER CARCINOMA; LIVER CELL CARCINOMA; MIXED TUMOR; MOLECULAR CLONING; NONHUMAN; ONCOGENE RAS; POINT MUTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; TELEOST;

MAMMALIA; ORYZIAS; ORYZIAS LATIPES; TELEOST FISH; TELEOSTEI;

EID: 0042388522     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(03)00133-5     Document Type: Article

References (44)

1. Hatanaka J., Doke N., Harada T., Aikawa T., Enomoto M. Usefulness of medaka in carcinogenesis studies. Jpn. J. Exp. Med. 52:1982;243-253.
2. Hinton D.E., Teh S.J., Okihiro M.S., Cooke J.B., Parker L.M. Phenotypically altered hepatocyte populations in diethylnitrosamine-induced medaka liver carcinogenesis: resistance, growth, and fate. Mar. Environ. Res. 34:1992;1-5.
3. Ishikawa T., Masahito P., Takayama S. Use of small fish species in carcinogenicity testing. Natl. Cancer Inst. Monogr. 65:1984;35-431.
4. Ishikawa T., Shimamine T., Takayama S. Histologic and electron microscope observations on diethylnitrosamine-induced hepatomas in small aquarium fish [Oryzial latipes]. J. Natl. Cancer Inst. 55:1975;909-916.
5. Lauren D.J., Teh S.J., Hinton D.E. Cytotoxicity phase of diethylnitrosamine-induced hepatic neoplasia in medaka. Cancer Res. 50:1990;5504-5514.
6. Masahito P., Aoki K., Egami N., Ishikawa T., Sugano H. Life-span studies on spontaneous tumor development in the medaka [Oryzias latipes]. Jpn. J. Cancer Res. 80:1989;1058-1065.
7. Van Beneden R.J., Walker C.W., Laughner E.S. Cloning of medaka p53 and evaluation of mutational hotspots in MNNG-exposed fish. Gene. 189:1997;101-106.
8. L.L. Clepper, R.J. Van Beneden, Cloning and sequence analysis of c-Ki-ras genes from the Japanese medaka (Oryzias latipes), personal communication.
9. J.M. Rotchell, J.S. Lee, J.K. Chipman, G.K. Ostrander, Structure, expression and activation of fish ras genes, Aquat. Toxicol. 55 (2001) 1-21.
10. Mangold K., Chang Y.J., Mathews C., Marien K., Hendrick J., Bailey G.S. Expression of ras genes in rainbow trout liver. Mol. Carcinog. 4:1991;97-102.
11. Nemoto N., Kodama K., Tazawa A., Matsumoto J., Masahito P., Ishikawa T. Nucleotide sequence comparison of the predicted first exonic region of goldfish ras gene between normal and neoplastic tissues. J. Cancer Res. Clin. Oncol. 113:1987;56-60.
12. R.J. Van Beneden, G.S. Ostrander, Expression of oncogenes and tumor suppressor genes in teleost fish, in: D.C. Malins, G.K. Ostrander (Eds.), Aquatic Toxicology, Molecular, Biochemical and Cellular Perspectives, Boca Raton, FL, Lewis Publishers, 1993, pp. 295-325.
13. Richardson K.K., Rexroat M.A., Helvering L.M., Copple D.M., Richardson F.C. Temporal changes in the mutant frequency and mutation spectra of the 61st codon of the H-ras oncogene following exposure of B6C3F1 mice to N-nitrosodiethylamine [DEN]. Carcinogenesis. 13:1992;1277-1279.
14. Rumsby P.C., Barrass N.C., Phillimore H.E., Evans J.G. Analysis of the Ha-ras oncogene in C3H/He mouse liver tumours derived spontaneously or induced with diethylnitrosamine or phenobarbitone. Carcinogenesis. 12:1992;2331-2336.
15. Hendricks J.D., Cheng R., Shelton D.W., Pereira C.B., Bailey G.S. Dose-dependent carcinogenicity and frequent Ki-ras proto-oncogene activation by dietary N-nitrosodiethylamine in rainbow trout. Fundam. Appl. Toxicol. 23:1992;53-62.
16. McMahon G., Huber L.I., Stegeman J.J., Wogen G.N. Identification of c-Ki-ras oncogene in a neoplasm isolated from winter flounder. Mar. Environ. Res. 23:1988;345-350.
17. Wirgin I., Currie D., Garte S.J. Activation of the K-ras oncogene in liver tumors of Hudson River Tomcod. Carcinogenesis. 10:1989;2311-2315.
18. Francoise V., de Boer J., Pfohl-Leszkowicz A., Cherrel Y., Galgani F. Two cases of ras mutation associated with liver hyperplasia in dragnets (Callionymus lyra) exposed to polychlorinated biphenyls and polycyclic aromatic hydrocarbons. Mol. Carcinog. 21:1998;121-127.
19. Roy N.K., Stabile J., Seeb J.E., Habicht C., Wirgin I. High frequency of K-ras mutations in pink salmon embryos experimentally exposed to Exxon Valdez oil. Environ. Toxicol. Chem. 18:1999;1521-1528.
20. DeKoven D.L., Nuneez J.M., Conklin D.E., Marty G.D., Parker L.M., Hinton D.E. A purified diet for medaka [Oryzias latipes]: refining a fish model for toxicological research. Lab. Anim. Sci. 42:1992;180-189.
21. Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chainterminating inhibitors. Proc. Natl. Acad. Sci. U.S.A. 74:1977;5463-5467.
22. Abrams E.S., Murdaugh S.E., Lerman L.S. Comprehensive screening of the human KRAS2 gene for sequence variants. Genes Chromosomes Cancer. 6:1993;73-85.
23. K.J. Kidd, Human gene mapping 10, Cytogenet. Cell Genet. 51 (1989).
24. Barbacid M. ras genes. Ann. Rev. Biochim. 70:1987;865-868.
25. Barbacid M. ras oncogenes: their role in neoplasia [review]. Eur. J. Clin. Invest. 20:1990;225-235.
26. Bos J. L. ras oncogenes in human cancer: a review. Cancer Res. 49:1989;4682-4689.
27. Leon J., Guerrero T.H., Pellicer A. Different expression of the ras gene family in mice. Mol. Cell. Biol. 7:1987;1535-1540.
28. Furth M.E., Aldrich T.H., Cordon-Cardo C. Expression of ras proto-oncogene proteins in normal human tissues. Oncogene. 1:1987;47-58.
29. Chesa P.G., Rettig W.J., Melamed M.R., Old L.J., Niman H.L. Expression of p21-ras in normal and malignant human tissues: lack of association with proliferation and malignancy. Proc. Natl. Acad. Sci. U.S.A. 84:1987;3234-3238.
30. Pells S., Divjak M., Romanowski P., Impey H., Hawkins N.J., Clarke A.R., Hooper M.L., Williamson D.J. Developmentally-regulated expression of murine K-ras isoforms. Oncogene. 15:1997;1781-1786.
31. Chang E.H., Furth M.E., Scolnick E., Lowy D.R. Tumorigenic transformation of mammaliam cells induced by a normal human gene homologous to the oncogene of harvey murine sarcoma virus. Nature. 297:1989;479-482.
32. Taparowsky E., Suard Y., Fasano O., Shimizu K., Goldfarb M., Wigler M. Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change. Nature. 300:1982;762-765.
33. Santos E., Reddy E.P., Pulciani S., Feldmann R.J., Barbacid M. Spontaneous activation of a human proto-oncogene. Proc. Natl. Acad. Sci. U.S.A. 80:1983;4670-4683.
34. Yamamoto F., Perucho M. Activation of a human c-K-ras oncogene. Nucl. Acid. Res. 12:1984;8873-8885.
35. Pulciani S., Santos E., Lauver A.V., Long L.K., Sorrentino V., Barbacid M. ras gene amplification and malignant transformation. Mol. Cell. Biol. 5:1985;2836-2841.
36. Schwab M., Alitalo K., Varmus H.E., Bishop J.M., George D.A. Cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumor cells. Nature. 303:1983;497-501.
37. Taya Y., Hosogai K., Hirahashi S., Shimosato Y., Tsuchiya R., Tsuchida N., Fushimi M., Sekiya T., Nishimura S. A novel combination of K-ras and myc amplificaiton accompanied by point mutational activation of K-ras in a human lung cancer. EMBO J. 3:1984;2943-2946.
38. Fujita J., Srivastava S.K., Kraus M.H., Rhim J.S., Tronick S.R., Aaronson S.A. Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tumors. Proc. Natl. Acad. Sci. U.S.A. 82:1985;3849-3853.
39. Heighway J., Hasleton P.S. c-K-ras amplification in human lung cancer. Br. J. Cancer. 53:1986;285-287.
40. Bishop M.J. Molecular themes in oncogenesis. Cell. 64:1991;235-248.
41. Manam S., Storer R.D., Rahalada S., Leander K.R., Kraynak A.R., Hammermeister C.L., Joslyn D.J., Ledwith B.J., van Zwieten M., Bradley M.O., Nichols W.W. Activation of the Ki-ras gene in spontaneous and chemically induced lung tumors in CD-1 Mice. Mol. Carcinog. 6:1992;68-75.
42. Bauer-Hofmann R., Buchmann A., Wright A.S., Schwarz M. Mutations in the Ha-ras proto-oncogene in spontaneous and chemically induced liver tumors of the CF1 mouse. Carcinogenesis. 11:1990;1875-1877.
43. Sigal I.S., Gibbs J.B., D'Alonzo J.S., Temeles G.L., Wolanski B.S., Socher S.H., Scolnick E.M. Mutant ras-encoded proteins with altered nucleotide binding exert dominant biological effects. Proc. Natl. Acad. Sci. U.S.A. 83:1986;952-956.
44. Gilman A.G. G proteins and dual control of adenylate cyclase. Cell. 36:1984;577-579.